[ Price : $8.95]
Former FDA commissioner Andrew C. von Eschenbach and former HHS secretary Tommy G. Thompson urge policymakers to prioritize leader...[ Price : $8.95]
A new policy report urges sweeping FDA reforms, arguing that shortening the time required to bring drugs, biologics and medical de...[ Price : $8.95]
FDA appoints Lisa Romano as principal deputy associate commissioner for inspections and investigations, elevating a 24-year agency...[ Price : $8.95]
Fulcrum Therapeutics says it is discontinuing development of its lead sickle cell disease candidate, pociredir, after receiving fe...[ Price : $8.95]
FDA and the drug industry conclude technical negotiations over the next iteration of the Prescription Drug User Fee Act, setting t...[ Price : $8.95]
An FDA crackdown on allegedly deceptive prescription drug advertising leads to a sharp increase in pharmaceutical advertising spen...[ Price : $8.95]
FDA posts a draft guidance that proposes streamlined nonclinical safety testing approaches for certain oncology biologics and conj...[ Price : $8.95]
ICH updates its long-running question-and-answer guidance tied to the ICH Q8, Q9 and Q10 pharmaceutical quality guidelines.